Dr Hill is the Director of the Lymphoid Malignancies Program and a Staff Physician in the Cleveland Clinic Taussig Cancer Institute.  He received his undergraduate degree from Dartmouth College and earned his Ph.D. in genetics through work done at Cold Spring Harbor Laboratory.  He received his medical degree from the University of Chicago Pritzker School of Medicine where he also completed his residency in Internal Medicine.  He completed his hematology/oncology fellowship at the Cleveland Clinic.   His clinical and research focus is in chronic lymphocytic leukemia (CLL) and lymphoma.  He is the principal investigator of multiple on-going clinical trials of new cancer treatments including novel cellular therapies

Dr Brian Hill has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Abbvie, AstraZeneca, Genetech, Gilead and Pharmacyclics